Related Experiment Video
Updated: Mar 20, 2026

A 3D Organotypic Melanoma Spheroid Skin Model
Published on: May 18, 2018
Malignant Melanoma With Rhabdomyosarcomatous Differentiation: A Case Report
Nina K Antonov1, George W Niedt
1*Department of Dermatology, Columbia University Medical Center, New York, NY; and †Department of Dermatology, Division of Dermatopathology, Columbia University Medical Center, New York, NY.
Malignant melanoma can rarely show divergent differentiation, mimicking other cell types. This case highlights the diagnostic difficulty of melanoma with rhabdomyosarcomatous differentiation.
Area of Science:
- Oncology
- Dermatopathology
- Skeletal Muscle Pathology
Background:
- Malignant melanoma can exhibit divergent differentiation, a rare phenomenon where tumor cells display features of non-melanocytic cell or tissue components.
- Melanoma with rhabdomyosarcomatous differentiation is exceptionally rare, with only six adult cases previously documented in scientific literature.
Observation:
- A 75-year-old male presented with a cutaneous lesion on his right ear, initially diagnosed as malignant melanoma.
- A subsequent biopsy of a right cervical lymph node revealed changes suggestive of rhabdomyosarcoma.
- Re-evaluation of the primary skin biopsy using specific muscle markers confirmed the presence of rhabdomyosarcomatous differentiation within the malignant melanoma.
Findings:
- The study confirms a rare case of malignant melanoma exhibiting rhabdomyosarcomatous differentiation.
- Diagnostic challenges arise due to the morphologic overlap between melanoma and rhabdomyosarcoma.
Implications:
- This case underscores the importance of considering divergent differentiation in challenging melanoma diagnoses.
- Accurate diagnosis requires careful histopathologic examination and the use of specific immunohistochemical markers.
- Increased awareness of this rare melanoma subtype is crucial for appropriate patient management and treatment strategies.
More Related Videos
09:21Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas
Published on: September 13, 2019
08:57Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
Published on: May 17, 2024